Protease inhibitors, diabetes mellitus and blood lipids

Diabetes and Metabolism

Volumn 24, Issue 6, 1998, Pages 547-549

  Meyer, L ^a   Rabaud, C ^a   Ziegler, O ^a   May, T ^a   Drouin, P ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Diabetes mellitus; Human immunodeficiency virus infection; Lipaemia; Protease inhibitors

Indexed keywords

C PEPTIDE; FENOFIBRATE; HEMOGLOBIN A1C; INDINAVIR; INSULIN; LAMIVUDINE; NEVIRAPINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; STAVUDINE; SULFONYLUREA; VIRUS RNA; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; BLOOD GLUCOSE MONITORING; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DIABETES CONTROL; DIABETES MELLITUS; DISEASE COURSE; DRUG WITHDRAWAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN INFUSION; MALE; SUBCUTANEOUS DRUG ADMINISTRATION; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD;

ADULT; DIABETES MELLITUS; HIV PROTEASE INHIBITORS; HIV SEROPOSITIVITY; HUMANS; LIPIDS; MALE;

EID: 0032432250     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Hammer SM, Squires KE, Hugues MD, et al. A controlled trial of two nucleoside analogs plus Indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med, 1997, 337, 725-733.
2. Albrecht H, Stellbrink HJ, Arasteh K. Didanosin-induced disorders of glucose tolerance. Ann Intern Med, 1993, 119, 1150.
3. Dubé MP, Johnson LD, Currier JS, et al. Protease inhibitor-associated hyperglycaemia. Lancet, 1997, 350, 713-714.
4. Lumpkin MM. Reports of diabetes and hyperglycaemia in patients receiving protease inhibitors for the treatment of human immunodeficiency virus (HIV). FDA Public Health Advisor); June 11, 1997.
5. Nunez EA, Christeff N. Steroid hormone, cytokine, lipid and metabolic disturbances in HIV infection. Baillière's Clinical Endocrinology and Metabolism, 1994, 8, 803-824.